Cargando…
Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway
The incidence of thyroid cancer (TC) continues to increase worldwide. Aerobic glycolysis, the prominent feature of glucose metabolism in cancer progression, is associated with TC. We first demonstrated that HIF-1a is highly expressed in TC tissues and is positively correlated with the level of XIST...
Autores principales: | Yang, Fei, Zhang, Jie, Zhao, Zhijun, Liu, Yan, Zhao, Zhen, Fu, Kai, Li, Baokun, Jin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085032/ https://www.ncbi.nlm.nih.gov/pubmed/37036874 http://dx.doi.org/10.1371/journal.pone.0284242 |
Ejemplares similares
-
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels
por: Wang, Miao, et al.
Publicado: (2022) -
LncRNA XIST modulates HIF‐1A/AXL signaling pathway by inhibiting miR‐93‐5p in colorectal cancer
por: Yang, Li‐guang, et al.
Publicado: (2020) -
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
por: Liu, L, et al.
Publicado: (2016) -
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
por: Liu, L, et al.
Publicado: (2017) -
Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells
por: Huang, Shi-Wei, et al.
Publicado: (2014)